| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Critical Care and Intensive Care Medicine | 121 / 122 | 1st | Q4 |
| Infectious Diseases | 358 / 361 | 0th | Q4 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Nederlands Tijdschrift voor Dermatologie en Venereologie
Nederlands Tijdschrift voor Dermatologie en Venereologie is Scopus-indexed (Q4, CiteScore 0.1). Published by Stichting Beheer Tijdschriften Dermatologie.
Checked against the index lists dated .
ISSN 0925-8604Verify ISSN ↗
Publisher: Stichting Beheer Tijdschriften Dermatologie
Cost to publish: No APC data — check the publisher
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Nederlands Tijdschrift voor Dermatologie en Venereologie indexed in Scopus?
Yes — actively indexed in Scopus, coverage 2004–present, best quartile Q4, CiteScore 0.1.
What quartile is Nederlands Tijdschrift voor Dermatologie en Venereologie in Scopus?
Nederlands Tijdschrift voor Dermatologie en Venereologie is Q4 in Critical Care and Intensive Care Medicine (rank 121 of 122) and Q4 in Infectious Diseases (rank 358 of 361), by CiteScore 2025.
What is the impact factor of Nederlands Tijdschrift voor Dermatologie en Venereologie?
Nederlands Tijdschrift voor Dermatologie en Venereologie is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 0.1, quartile Q4, 1st percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.100, quartile Q4, with an H-index of 5.
Who publishes Nederlands Tijdschrift voor Dermatologie en Venereologie and what is its ISSN?
Nederlands Tijdschrift voor Dermatologie en Venereologie is published by Stichting Beheer Tijdschriften Dermatologie. Its ISSN is 0925-8604.
Is Nederlands Tijdschrift voor Dermatologie en Venereologie in Web of Science?
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Nederlands Tijdschrift voor Dermatologie en Venereologie open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
How well cited is Nederlands Tijdschrift voor Dermatologie en Venereologie? — open metrics via OpenAlex
Nederlands Tijdschrift voor Dermatologie en Venereologie has an h-index of 2 and a 2-year mean of 0 citations per paper (OpenAlex). Its Scopus CiteScore is 0.1, quartile Q4. On 2-year citations it ranks #111 of 117 Scopus journals in Critical Care and Intensive Care Medicine.
Nederlands Tijdschrift voor Dermatologie en Venereologie published 12 papers in 2020; its busiest recent year was 2012 with 25. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Are there integrity warnings for Nederlands Tijdschrift voor Dermatologie en Venereologie? — indicators, not proof of misconduct
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers None recorded
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.